Gut Microbiota Dysbiosis Aggravates Mycoplasma gallisepticum Colonization in the Chicken Lung

Jian Wang1, Xueping Chen1, Jichang Li2

  • 1College of Veterinary Medicine, Shanxi Agricultural University, Jinzhong, China.

Insights

Disrupting gut microbiota in chickens worsens Mycoplasma gallisepticum (MG) lung infection. Restoring gut health with butyric acid or vitamin A aids MG clearance by boosting immune responses.

Area of Science:

  • Veterinary Immunology
  • Microbiome Research
  • Avian Pathology

Background:

  • Mycoplasma gallisepticum (MG) causes chronic respiratory disease in chickens.
  • The gut microbiota's role in respiratory health and MG infection resistance is unclear.
  • Understanding this link is crucial for poultry health management.

Purpose of the Study:

  • To investigate the correlation between gut microbiota composition and MG infection in chickens.
  • To determine if gut microbiota dysbiosis impacts the pulmonary immune response to MG.
  • To explore potential therapeutic strategies targeting the gut microbiota for MG control.

Main Methods:

  • Antibiotic cocktail used to induce gut microbiota dysbiosis in chickens.
  • MG colonization in the lungs assessed.
  • Immune responses evaluated, including Toll-like receptor 2 (TLR2), IL-17, and GM-CSF.
  • Short-chain fatty acids (SCFAs) and vitamin A levels measured.
  • Effects of butyric acid and vitamin A supplementation studied.

Main Results:

  • Gut microbiota dysbiosis significantly increased MG colonization in the lungs.
  • Dysbiosis impaired pulmonary immune response, evidenced by reduced TLR2, IL-17, and GM-CSF.
  • Intranasal administration of TLR2 ligand, IL-17, or GM-CSF partially reversed MG colonization.
  • Reduced levels of SCFAs and vitamin A observed in dysbiosis group.
  • Butyric acid or vitamin A supplementation promoted MG clearance via enhanced immune gene expression.

Conclusions:

  • Gut microbiota plays a critical role in defending against Mycoplasma gallisepticum colonization in the chicken lung.
  • Gut microbiota dysbiosis compromises the pulmonary immune defense against MG infection.
  • Butyric acid and vitamin A show potential as feed additives to enhance resistance to MG infection by modulating the gut microbiota and immune pathways.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...